BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2591023)

  • 21. Effects of tumor promoters on sodium ion transport across frog skin.
    Civan MM; Rubenstein D; Mauro T; O'Brien TG
    Am J Physiol; 1985 May; 248(5 Pt 1):C457-65. PubMed ID: 2986464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanistic aspects of the delay in the G2 phase of the cell cycle caused by tumor promoter 12-O-tetradecanoylphorbol-13-acetate in HeLa cells.
    Kinzel V; Richards J; Marks F; Fürstenberger G
    Carcinogenesis; 1985 Sep; 6(9):1375-8. PubMed ID: 4028335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiomimetic activity of phorbol esters exerted in HeLa cells in comparison with their tumor-promoting capacity.
    Kinzel V; Richards J; Marks F; Fürstenberger G
    Cancer Res; 1984 Jan; 44(1):139-43. PubMed ID: 6690031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-promoting phorbol esters affect production of prolactin and growth hormone by rat pituitary cells.
    Osborne R; Tashjian AH
    Endocrinology; 1981 Apr; 108(4):1164-70. PubMed ID: 7472264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A proposed common mechanism by which phorbol esters and epidermal growth factor delay the progression from G2 phase to mitosis of HeLa cells through phospholipid metabolites.
    Kaszkin M; Fürstenberger G; Richards J; Seidler L; Kinzel V
    Cancer Res; 1991 Aug; 51(16):4328-35. PubMed ID: 1868456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of the arachidonic acid metabolite 8-HETE by extracts of mouse skin treated with phorbol ester in vivo; identification by 1H-n.m.r. and GC-MS spectroscopy.
    Gschwendt M; Fürstenberger G; Kittstein W; Besemfelder E; Hull WE; Hagedorn H; Opferkuch HJ; Marks F
    Carcinogenesis; 1986 Mar; 7(3):449-55. PubMed ID: 3081276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of protein phosphatase 2A activity in HeLa cells at the G2-mitosis transition and unscheduled reactivation induced by 12-O-tetradecanoyl phorbol-13-acetate (TPA).
    Klingler-Hoffmann M; Barth H; Richards J; König N; Kinzel V
    Eur J Cell Biol; 2005 Aug; 84(8):719-32. PubMed ID: 16180310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phorbol ester TPA rapidly prevents activation of p34cdc2 histone H1 kinase and concomitantly the transition from G2 phase to mitosis in synchronized HeLa cells.
    Barth H; Kinzel V
    Exp Cell Res; 1994 Jun; 212(2):383-8. PubMed ID: 8187833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overproduction of the beta 1 form of protein kinase C enhances phorbol ester induction of glucose transporter mRNA.
    Mountjoy KG; Housey GM; Flier JS
    Mol Endocrinol; 1989 Dec; 3(12):2018-27. PubMed ID: 2628736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of suppressor activity by tumor-promoting phorbol esters in primary cultures of lymph node cells.
    Hurley DJ; Mastro AM
    Carcinogenesis; 1987 Mar; 8(3):357-62. PubMed ID: 2949882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor promoter-induced refractory state against ornithine decarboxylase induction by 12-O-tetradecanoylphorbol-13-acetate in mouse epidermis.
    Takigawa M; Simsiman RC; Boutwell RK
    Cancer Res; 1986 Jan; 46(1):106-12. PubMed ID: 3940182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumour-promoting and hyperplastic effects of phorbol and daphnane esters in CD-1 mouse skin and a synergistic effect of calcium ionophore with the non-promoting activator of protein kinase C, sapintoxin A.
    Brooks G; Evans AT; Aitken A; Evans FJ
    Carcinogenesis; 1989 Feb; 10(2):283-8. PubMed ID: 2912580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of tumor promoters on the rate and commitment to terminal differentiation of subpopulations of murine keratinocytes.
    Reiners JJ; Slaga TJ
    Cell; 1983 Jan; 32(1):247-55. PubMed ID: 6186392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tephrosia purpurea alleviates phorbol ester-induced tumor promotion response in murine skin.
    Saleem M; Ahmed Su ; Alam A; Sultana S
    Pharmacol Res; 2001 Feb; 43(2):135-44. PubMed ID: 11243714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of human promyelocytic leukemia cell (HL60) variants insensitive to phorbol ester tumor promoters.
    Mascioli DW; Estensen RD
    Cancer Res; 1984 Aug; 44(8):3280-5. PubMed ID: 6331641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intercellular communication is reduced by TPA and Ki-ras p21 in quiescent, but not proliferating, NRK cells.
    Paulson AF; Johnson RG; Atkinson MM
    Exp Cell Res; 1994 Jul; 213(1):64-70. PubMed ID: 8020607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the hydroperoxide response observed in mouse skin treated with tumor promoters in vivo.
    Perchellet EM; Perchellet JP
    Cancer Res; 1989 Nov; 49(22):6193-201. PubMed ID: 2509065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of phorbol ester tumor promoters on the expression of melanogenesis in B-16 melanoma cells.
    Mufson RA; Fisher PB; Weinstein IB
    Cancer Res; 1979 Oct; 39(10):3915-9. PubMed ID: 476628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of the response of HELA cells towards the radiomimetic activity of 12-O-tetradecanoylphorbol-13-acetate.
    Kinzel V; Düzgün F; Richards J
    Cancer Lett; 1982 Oct; 17(1):45-50. PubMed ID: 7151053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of collagen-degrading enzymes in the dermis after one topical application of tumor-promoting phorbol esters.
    Marian B
    Carcinogenesis; 1986 May; 7(5):723-6. PubMed ID: 3084115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.